Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
Abstract The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various i...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c2748112d5144559995d02d8385bb8d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:c2748112d5144559995d02d8385bb8d9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:c2748112d5144559995d02d8385bb8d92021-12-02T15:07:51ZMaresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression10.1038/s41598-018-23623-92045-2322https://doaj.org/article/c2748112d5144559995d02d8385bb8d92018-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-23623-9https://doaj.org/toc/2045-2322Abstract The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various inflammatory disease models. However, the effect of topical MaR1 on cutaneous inflammation remains unclear. Therefore, we initially examined the anti-inflammatory effects of topical Maresin-1 using an imiquimod (IMQ)-induced psoriasis-like mouse model of inflammation. Topical MaR1 reduced the ear swelling response as seen in histological findings. RT-PCR and flow cytometry analyses revealed MaR1 had no inhibitory effect on IL-23, but MaR1 suppressed IL-17A production by γδTCRmid+ and CD4+ cells in the skin. These inhibitory effects were also observed in a subcutaneous IL-23-injected psoriasis model. MaR1 downmodulated IL-23 receptor (IL-23R) expression by suppressing retinoic acid-related orphan receptor γt (RORγt) expression and internalization in a clathrin-dependent manner in γδTCRmid+ and CD4+ cells. These results lead to assumptions that topical MaR1 may be a new therapeutic agent for psoriasis and other IL-17-mediated cutaneous inflammatory diseases.Natsuko Saito-SasakiYu SawadaEmi MashimaTakashi YamaguchiShun OhmoriHaruna YoshiokaSanehito HaruyamaEtsuko OkadaMotonobu NakamuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Natsuko Saito-Sasaki Yu Sawada Emi Mashima Takashi Yamaguchi Shun Ohmori Haruna Yoshioka Sanehito Haruyama Etsuko Okada Motonobu Nakamura Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression |
description |
Abstract The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various inflammatory disease models. However, the effect of topical MaR1 on cutaneous inflammation remains unclear. Therefore, we initially examined the anti-inflammatory effects of topical Maresin-1 using an imiquimod (IMQ)-induced psoriasis-like mouse model of inflammation. Topical MaR1 reduced the ear swelling response as seen in histological findings. RT-PCR and flow cytometry analyses revealed MaR1 had no inhibitory effect on IL-23, but MaR1 suppressed IL-17A production by γδTCRmid+ and CD4+ cells in the skin. These inhibitory effects were also observed in a subcutaneous IL-23-injected psoriasis model. MaR1 downmodulated IL-23 receptor (IL-23R) expression by suppressing retinoic acid-related orphan receptor γt (RORγt) expression and internalization in a clathrin-dependent manner in γδTCRmid+ and CD4+ cells. These results lead to assumptions that topical MaR1 may be a new therapeutic agent for psoriasis and other IL-17-mediated cutaneous inflammatory diseases. |
format |
article |
author |
Natsuko Saito-Sasaki Yu Sawada Emi Mashima Takashi Yamaguchi Shun Ohmori Haruna Yoshioka Sanehito Haruyama Etsuko Okada Motonobu Nakamura |
author_facet |
Natsuko Saito-Sasaki Yu Sawada Emi Mashima Takashi Yamaguchi Shun Ohmori Haruna Yoshioka Sanehito Haruyama Etsuko Okada Motonobu Nakamura |
author_sort |
Natsuko Saito-Sasaki |
title |
Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression |
title_short |
Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression |
title_full |
Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression |
title_fullStr |
Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression |
title_full_unstemmed |
Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression |
title_sort |
maresin-1 suppresses imiquimod-induced skin inflammation by regulating il-23 receptor expression |
publisher |
Nature Portfolio |
publishDate |
2018 |
url |
https://doaj.org/article/c2748112d5144559995d02d8385bb8d9 |
work_keys_str_mv |
AT natsukosaitosasaki maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT yusawada maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT emimashima maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT takashiyamaguchi maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT shunohmori maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT harunayoshioka maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT sanehitoharuyama maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT etsukookada maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression AT motonobunakamura maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression |
_version_ |
1718388414323097600 |